AlphaCrest Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,359
| Closed | -$889K | – | 1250 |
|
|
2022
Q3 | $889K | Sell |
14,359
-127,857
| -90% | -$7.92M | 0.05% | 687 |
|
|
2022
Q2 | $11.3M | Buy |
142,216
+100,584
| +242% | +$8.02M | 0.55% | 9 |
|
|
2022
Q1 | $4.38M | Sell |
41,632
-14,474
| -26% | -$1.52M | 0.24% | 62 |
|
|
2021
Q4 | $6.05M | Buy |
56,106
+43,949
| +362% | +$4.74M | 0.22% | 70 |
|
|
2021
Q3 | $1.33M | Sell |
12,157
-806
| -6% | -$88.3K | 0.07% | 487 |
|
|
2021
Q2 | $1.21M | Sell |
12,963
-4,689
| -27% | -$439K | 0.05% | 569 |
|
|
2021
Q1 | $1.63M | Buy |
17,652
+1,959
| +12% | +$180K | 0.09% | 332 |
|
|
2020
Q4 | $1.15M | Buy |
+15,693
| New | +$1.15M | 0.1% | 272 |
|
|
2020
Q2 | – | Sell |
-22,391
| Closed | -$663K | – | 1206 |
|
|
2020
Q1 | $663K | Buy |
+22,391
| New | +$663K | 0.08% | 446 |
|
|
2019
Q3 | – | Sell |
-11,351
| Closed | -$273K | – | 1391 |
|
|
2019
Q2 | $273K | Buy |
+11,351
| New | +$273K | 0.02% | 891 |
|